2023 Q1 Form 10-Q Financial Statement
#000121390023040499 Filed on May 16, 2023
Income Statement
Concept | 2023 Q1 | 2022 Q1 |
---|---|---|
Revenue | $0.00 | $0.00 |
YoY Change | ||
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $1.078M | $191.0K |
YoY Change | 464.4% | -13.18% |
% of Gross Profit | ||
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | ||
YoY Change | ||
% of Gross Profit | ||
Operating Expenses | -$1.883M | $191.0K |
YoY Change | -1085.86% | -13.18% |
Operating Profit | $1.883M | -$191.0K |
YoY Change | -1085.86% | |
Interest Expense | $100.0K | $25.00K |
YoY Change | 300.0% | -50.0% |
% of Operating Profit | 5.31% | |
Other Income/Expense, Net | $800.0K | $6.849M |
YoY Change | -88.32% | 42.69% |
Pretax Income | $914.0K | $6.683M |
YoY Change | -86.32% | 44.34% |
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | $882.0K | $6.683M |
YoY Change | -86.8% | 44.34% |
Net Earnings / Revenue | ||
Basic Earnings Per Share | ||
Diluted Earnings Per Share | $0.08 | $178.2K |
COMMON SHARES | ||
Basic Shares Outstanding | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2023 Q1 | 2022 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $3.000K | $528.0K |
YoY Change | -99.43% | -62.29% |
Cash & Equivalents | $3.000K | $528.0K |
Short-Term Investments | ||
Other Short-Term Assets | $206.0K | $191.0K |
YoY Change | 7.85% | -52.25% |
Inventory | ||
Prepaid Expenses | $206.0K | |
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $209.0K | $719.0K |
YoY Change | -70.93% | -60.06% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $5.000M | |
YoY Change | ||
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | $41.00M | $300.1M |
YoY Change | -86.34% | 0.03% |
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | $41.00M | $300.1M |
YoY Change | -86.34% | 0.03% |
TOTAL ASSETS | ||
Total Short-Term Assets | $209.0K | $719.0K |
Total Long-Term Assets | $41.00M | $300.1M |
Total Assets | $41.21M | $300.8M |
YoY Change | -86.3% | -0.32% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $11.00K | $26.00K |
YoY Change | -57.69% | |
Accrued Expenses | $828.0K | $2.668M |
YoY Change | -68.97% | 1234.0% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $1.359M | $0.00 |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $2.198M | $2.694M |
YoY Change | -18.41% | 1247.0% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $12.86M | $16.57M |
YoY Change | -22.41% | -38.17% |
Total Long-Term Liabilities | $12.86M | $16.57M |
YoY Change | -22.41% | -38.17% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $2.198M | $2.694M |
Total Long-Term Liabilities | $12.86M | $16.57M |
Total Liabilities | $15.06M | $19.27M |
YoY Change | -21.85% | -28.65% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$14.85M | |
YoY Change | ||
Common Stock | $0.00 | |
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | -$14.85M | -$18.45M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $41.21M | $300.8M |
YoY Change | -86.3% | -0.32% |
Cashflow Statement
Concept | 2023 Q1 | 2022 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | $882.0K | $6.683M |
YoY Change | -86.8% | 44.34% |
Depreciation, Depletion And Amortization | ||
YoY Change | ||
Cash From Operating Activities | -$567.0K | -$314.0K |
YoY Change | 80.57% | -34.58% |
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $264.6M | $0.00 |
YoY Change | -100.0% | |
Cash From Investing Activities | $264.6M | $0.00 |
YoY Change | -100.0% | |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | $265.1M | $0.00 |
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | -$264.1M | 0.000 |
YoY Change | -100.0% | |
NET CHANGE | ||
Cash From Operating Activities | -$567.0K | -314.0K |
Cash From Investing Activities | $264.6M | 0.000 |
Cash From Financing Activities | -$264.1M | 0.000 |
Net Change In Cash | -$98.00K | -314.0K |
YoY Change | -68.79% | -122.59% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$567.0K | -$314.0K |
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
8000 | usd |
CY2023Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2023Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2023Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-03-31 | |
CY2023Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2023Q1 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023Q1 | dei |
Entity File Number
EntityFileNumber
|
001-39875 | |
CY2023Q1 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
E9 | |
CY2023Q1 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
200 Park Avenue | |
CY2023Q1 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
32nd Floor | |
CY2023Q1 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
New York | |
CY2023Q1 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NY | |
CY2023Q1 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
10166 | |
CY2023Q1 | dei |
City Area Code
CityAreaCode
|
(646) | |
CY2023Q1 | dei |
Local Phone Number
LocalPhoneNumber
|
585-8975 | |
CY2023Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2023Q1 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2023Q1 | dei |
Entity Shell Company
EntityShellCompany
|
true | |
CY2023Q1 | us-gaap |
Cash
Cash
|
3000 | usd |
CY2022Q4 | us-gaap |
Cash
Cash
|
101000 | usd |
CY2023Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
206000 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
8000 | usd |
CY2023Q1 | us-gaap |
Assets Current
AssetsCurrent
|
209000 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
109000 | usd |
CY2023Q1 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
40996000 | usd |
CY2022Q4 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
304675000 | usd |
CY2023Q1 | us-gaap |
Assets
Assets
|
41205000 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
304784000 | usd |
CY2023Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
11000 | usd |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
75000 | usd |
CY2023Q1 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
755000 | usd |
CY2022Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
785000 | usd |
CY2023Q1 | us-gaap |
Other Notes Payable
OtherNotesPayable
|
604000 | usd |
CY2023Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
828000 | usd |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
3016000 | usd |
CY2023Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2198000 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3876000 | usd |
CY2023Q1 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
2357000 | usd |
CY2022Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
467000 | usd |
CY2023Q1 | us-gaap |
Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
|
10500000 | usd |
CY2022Q4 | us-gaap |
Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
|
10500000 | usd |
CY2023Q1 | us-gaap |
Liabilities
Liabilities
|
15055000 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
14843000 | usd |
CY2023Q1 | gpac |
Ordinary Shares Subject To Possible Redemption
OrdinarySharesSubjectToPossibleRedemption
|
3931719 | shares |
CY2022Q4 | gpac |
Ordinary Shares Subject To Possible Redemption
OrdinarySharesSubjectToPossibleRedemption
|
30000000 | shares |
CY2023Q1 | us-gaap |
Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
|
10.42 | |
CY2022Q4 | us-gaap |
Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
|
10.15 | |
CY2023Q1 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
40996000 | usd |
CY2022Q4 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
304675000 | usd |
CY2023Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2023Q1 | gpac |
Common Stock One Value
CommonStockOneValue
|
1000 | usd |
CY2022Q4 | gpac |
Common Stock One Value
CommonStockOneValue
|
1000 | usd |
CY2023Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-14847000 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-14735000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-14846000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-14734000 | usd |
CY2023Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
41205000 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
304784000 | usd |
CY2023Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1078000 | usd |
CY2022Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
191000 | usd |
CY2023Q1 | gpac |
Settlement And Release Of Liabilities1
SettlementAndReleaseOfLiabilities1
|
2961000 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
1883000 | usd |
CY2022Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-191000 | usd |
CY2023Q1 | us-gaap |
Interest Income Other
InterestIncomeOther
|
921000 | usd |
CY2022Q1 | us-gaap |
Interest Income Other
InterestIncomeOther
|
25000 | usd |
CY2023Q1 | gpac |
Write Off Contingent Warrants Associated With Shares Redeemed
WriteOffContingentWarrantsAssociatedWithSharesRedeemed
|
130000 | usd |
CY2023Q1 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
-32000 | usd |
CY2023Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
2020000 | usd |
CY2022Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-6849000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
882000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
6683000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-14734000 | usd |
CY2023Q1 | gpac |
Accretion In Value Of Class A Ordinary Shares Subject To Redemption
AccretionInValueOfClassAOrdinarySharesSubjectToRedemption
|
1371000 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
377000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
882000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-14846000 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-25128000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
6683000 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-18445000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
882000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
6683000 | usd |
CY2023Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
921000 | usd |
CY2022Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
25000 | usd |
CY2023Q1 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
-32000 | usd |
CY2023Q1 | gpac |
Change In Fair Value Of Warrant Liability
ChangeInFairValueOfWarrantLiability
|
-1890000 | usd |
CY2022Q1 | gpac |
Change In Fair Value Of Warrant Liability
ChangeInFairValueOfWarrantLiability
|
6849000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
198000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-64000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-109000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-2188000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-6000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-567000 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-314000 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
|
450000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Decommissioning Fund
ProceedsFromDecommissioningFund
|
265050000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
264600000 | usd |
CY2023Q1 | gpac |
Redemption Of Common Shares
RedemptionOfCommonShares
|
26068281 | shares |
CY2022Q1 | gpac |
Redemption Of Common Shares
RedemptionOfCommonShares
|
26068281 | shares |
CY2023Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
265050000 | usd |
CY2023Q1 | gpac |
Repay Sponsor Working Capital Loan
RepaySponsorWorkingCapitalLoan
|
30000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
|
949000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-264131000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-98000 | usd |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-314000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
101000 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
842000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
3000 | usd |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
528000 | usd |
CY2022Q1 | gpac |
Deferred Underwriter Compensation
DeferredUnderwriterCompensation
|
10500000 | usd |
CY2022Q1 | gpac |
Offering Costs Included In Offering Costs Payable And Accrued
OfferingCostsIncludedInOfferingCostsPayableAndAccrued
|
70000 | usd |
CY2023Q1 | gpac |
Shares Redemption Percentage
SharesRedemptionPercentage
|
0.87 | pure |
CY2023Q1 | gpac |
Proceeds From Public Offering
ProceedsFromPublicOffering
|
300000000 | usd |
CY2021Q1 | gpac |
Trust Account
TrustAccount
|
300000000 | usd |
CY2023Q1 | gpac |
Redemption Price Per Share
RedemptionPricePerShare
|
10.167 | |
CY2023Q1 | us-gaap |
Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
|
265050000 | usd |
CY2023Q1 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
3000000 | usd |
CY2023Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
2961000 | usd |
CY2023Q1 | us-gaap |
Interest Expense
InterestExpense
|
100000 | usd |
CY2023Q1 | gpac |
Shares Redemption Percentage
SharesRedemptionPercentage
|
1 | pure |
CY2023Q1 | us-gaap |
Payments For Proceeds From Deposit On Loan
PaymentsForProceedsFromDepositOnLoan
|
150000 | usd |
CY2023Q1 | us-gaap |
Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
|
300000 | usd |
CY2023Q1 | gpac |
Taxes Payable On Interest Earned Percentage
TaxesPayableOnInterestEarnedPercentage
|
0.80 | pure |
CY2023Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
5000001 | usd |
CY2023Q1 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
10 | |
CY2023Q1 | us-gaap |
Assets Held In Trust
AssetsHeldInTrust
|
300000000 | usd |
CY2023Q1 | us-gaap |
Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
|
30000000 | shares |
CY2023Q1 | gpac |
Dissolution Expenses
DissolutionExpenses
|
100000 | usd |
CY2021 | gpac |
Offering Costs
OfferingCosts
|
16254000 | usd |
CY2021 | us-gaap |
Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
|
30354000 | usd |
CY2023Q1 | us-gaap |
Investments And Cash
InvestmentsAndCash
|
3000 | usd |
CY2023Q1 | gpac |
Negative Working Capital
NegativeWorkingCapital
|
1989000 | usd |
CY2023Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
11221954 | shares |
CY2022 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
15566667 | shares |
CY2023Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Concentration of Credit Risk: </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> | |
CY2023Q1 | us-gaap |
Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
|
250000 | usd |
CY2023Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Use of Estimates:</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> | |
CY2023Q1 | gpac |
Total Offering Cost
TotalOfferingCost
|
17054000 | usd |
CY2023Q1 | gpac |
Underwriters Discount
UnderwritersDiscount
|
16500000 | usd |
CY2023Q1 | us-gaap |
Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
|
16254000 | usd |
CY2023Q1 | us-gaap |
Other Expenses
OtherExpenses
|
800000 | usd |
CY2023Q1 | us-gaap |
Other Intangible Assets Net
OtherIntangibleAssetsNet
|
5000001 | usd |
CY2023Q1 | gpac |
Permanent Equity Shares
PermanentEquityShares
|
3931719 | shares |
CY2022Q4 | gpac |
Permanent Equity Shares
PermanentEquityShares
|
30000000 | shares |
CY2021Q4 | gpac |
Permanent Equity Shares
PermanentEquityShares
|
30000000 | shares |
CY2021 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
300000000 | usd |
CY2021 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
14100000 | usd |
CY2021 | us-gaap |
Temporary Equity Issue Period Increase Or Decrease
TemporaryEquityIssuePeriodIncreaseOrDecrease
|
300000000 | usd |
CY2022 | us-gaap |
Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
|
4675000 | usd |
CY2022Q4 | us-gaap |
Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
|
304675000 | usd |
CY2023Q1 | gpac |
Class A Ordinary Shares Redeemed
ClassAOrdinarySharesRedeemed
|
-265050000 | usd |
CY2023Q1 | us-gaap |
Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
|
1371000 | usd |
CY2023Q1 | gpac |
Ordinary Shares Subject To Redemption Total
OrdinarySharesSubjectToRedemptionTotal
|
40996000 | usd |
CY2021Q1 | us-gaap |
Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
|
30000000 | shares |
CY2021Q1 | gpac |
Share Purchase Price
SharePurchasePrice
|
10 | |
CY2023Q1 | us-gaap |
Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
|
P5Y | |
CY2023Q1 | gpac |
Redeemable Warrants
RedeemableWarrants
|
0.01 | |
CY2023Q1 | gpac |
Ordinary Shares Equals Exceeds
OrdinarySharesEqualsExceeds
|
18 | |
CY2023Q1 | gpac |
Underwriting Discount Percentage
UnderwritingDiscountPercentage
|
0.02 | pure |
CY2023Q1 | us-gaap |
Other Underwriting Expense
OtherUnderwritingExpense
|
6000000 | usd |
CY2023Q1 | gpac |
Deferred Underwriting Percentage
DeferredUnderwritingPercentage
|
0.035 | pure |
CY2023Q1 | gpac |
Deferred Underwriting Fees Payable
DeferredUnderwritingFeesPayable
|
10500000 | usd |
CY2023Q1 | gpac |
Redemption Price Per Share
RedemptionPricePerShare
|
10.167 | |
CY2023Q1 | us-gaap |
Redeemable Noncontrolling Interest Equity Redemption Value
RedeemableNoncontrollingInterestEquityRedemptionValue
|
265050166 | usd |
CY2023Q1 | gpac |
Contingent Redeemable Warrants
ContingentRedeemableWarrants
|
4344714 | shares |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
26068281 | shares |
CY2023Q1 | us-gaap |
Liability For Catastrophe Claims Carrying Amount
LiabilityForCatastropheClaimsCarryingAmount
|
130000 | usd |
CY2023Q1 | gpac |
Founder Share Vesting Description
FounderShareVestingDescription
|
The Founder Shares are substantially identical to the Class A ordinary shares included in the Units sold in the Public Offering except that the Founder Shares automatically convert into Class A ordinary shares at the time of the initial Business Combination, or at any time prior thereto at the option of the holder, and are subject to certain transfer restrictions, as described in more detail below, and the Founder Shares are subject to vesting as follows: 50% upon the completion of a Business Combination and then 12.5% on each of the attainment of Return to Shareholders (as defined in the agreement) exceeding 20%, 30%, 40% and 50%. Certain events, as defined in the agreement, could trigger an immediate vesting under certain circumstances. Founder Shares that do not vest within an eight-year period from the closing of the Business Combination will be cancelled. | |
CY2020Q4 | gpac |
Aggregate Loan Amount
AggregateLoanAmount
|
300000 | usd |
CY2020Q4 | us-gaap |
Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
|
1000 | usd |
CY2022Q3 | gpac |
Principal Amount
PrincipalAmount
|
2000000 | usd |
CY2023Q1 | us-gaap |
Loans Payable
LoansPayable
|
30000 | usd |
CY2022 | gpac |
Outstanding Principal Balance
OutstandingPrincipalBalance
|
755000 | usd |
CY2023Q1 | gpac |
Outstanding Principal Balance
OutstandingPrincipalBalance
|
785000 | usd |
CY2023Q1 | gpac |
Unpaid Principal Amount
UnpaidPrincipalAmount
|
250000 | usd |
CY2023Q1 | gpac |
Valuations Fair Value
ValuationsFairValue
|
572000 | usd |
CY2023Q1 | gpac |
Drawdown Shares
DrawdownShares
|
377000 | shares |
CY2023Q1 | us-gaap |
Proceeds From Other Equity
ProceedsFromOtherEquity
|
377000 | usd |
CY2023Q1 | us-gaap |
Hedged Asset Fair Value Hedge Cumulative Increase Decrease
HedgedAssetFairValueHedgeCumulativeIncreaseDecrease
|
32000 | usd |
CY2023Q1 | us-gaap |
Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
|
604000 | usd |
CY2023Q1 | gpac |
Outstanding Principal Balances
OutstandingPrincipalBalances
|
345000 | usd |
CY2022Q3 | gpac |
Extension Promissory Notes Related Party
ExtensionPromissoryNotesRelatedParty
|
604000 | usd |
CY2022Q3 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
604000 | usd |
CY2022Q1 | us-gaap |
Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
|
usd | |
CY2022Q1 | us-gaap |
Proceeds From Decommissioning Fund
ProceedsFromDecommissioningFund
|
usd | |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | |
CY2022Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
usd | |
CY2022Q1 | us-gaap |
Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
|
usd | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
|
1.5 | |
CY2023Q1 | us-gaap |
Share Price
SharePrice
|
3.63 | |
CY2023Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.03 | pure |
CY2023Q1 | gpac |
Implied Probability Of Merger Successin Shares
ImpliedProbabilityOfMergerSuccessinShares
|
0.60 | pure |
CY2023Q1 | us-gaap |
Other Borrowings
OtherBorrowings
|
300000 | usd |
CY2023Q1 | gpac |
Additional Borrowing
AdditionalBorrowing
|
20000 | usd |
CY2023Q1 | us-gaap |
Sponsor Fees
SponsorFees
|
25000 | usd |
CY2023Q1 | us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
75000 | usd |
CY2022Q1 | us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
75000 | usd |
CY2023Q1 | us-gaap |
Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
|
50000 | usd |
CY2022Q4 | us-gaap |
Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
|
0 | usd |
CY2023Q1 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
15566667 | shares |
CY2022Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
11221954 | shares |
CY2023Q1 | gpac |
Contingent Redeemable Warrants
ContingentRedeemableWarrants
|
4344714 | shares |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
26068281 | shares |
CY2023Q1 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
2357000 | usd |
CY2022Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
467000 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
usd | |
CY2023Q1 | gpac |
Deferred Underwriter Compensation
DeferredUnderwriterCompensation
|
usd | |
CY2023Q1 | gpac |
Offering Costs Included In Offering Costs Payable And Accrued
OfferingCostsIncludedInOfferingCostsPayableAndAccrued
|
usd | |
CY2023Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
shares | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
shares | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
shares | |
CY2023Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
shares | |
CY2023Q1 | us-gaap |
Fair Value Concentration Of Risk Federal Funds Sold And Securities Borrowed Or Purchased Under Agreements To Resell
FairValueConcentrationOfRiskFederalFundsSoldAndSecuritiesBorrowedOrPurchasedUnderAgreementsToResell
|
300000000 | usd |
CY2023Q1 | us-gaap |
Auction Market Preferred Securities Shares Redeemed
AuctionMarketPreferredSecuritiesSharesRedeemed
|
26068281 | shares |
CY2023Q1 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
10.167 | |
CY2023Q1 | gpac |
Common Stock Redemption Amount
CommonStockRedemptionAmount
|
265050000 | usd |
CY2023Q1 | gpac |
Common Stock In Total
CommonStockInTotal
|
550000000 | shares |
CY2023Q1 | us-gaap |
Business Combination Control Obtained Description
BusinessCombinationControlObtainedDescription
|
The Founder Shares are subject to vesting as follows: 50% upon the completion of a Business Combination and then an additional 12.5% on the attainment of each of a series of certain “shareholder return” targets exceeding 20%, 30%, 40% and 50%, as further defined in the agreement. Certain events, as defined in the agreement, could trigger an immediate vesting under certain circumstances. Founder Shares that do not vest within an eight-year period from the closing of the Business Combination will be cancelled. | |
CY2023Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2023Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q1 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.01 | pure |
CY2023Q1 | us-gaap |
Fair Value Investments Entities That Calculate Net Asset Value Per Share Percent Equity Securities
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePercentEquitySecurities
|
0.01 | pure |
CY2023Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2023Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
Global Partner Acquisition Corp II | |
CY2023Q1 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
00-0000000 | |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
usd | |
CY2023Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2023Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001831979 |